Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07808060 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight

Name: A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight — clinical trial record (NCT07808060)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorEli Lilly and Company

Started2026-09

View on ClinicalTrials.gov ↗

The main purpose of this study is to evaluate how eloralintide (LY3841136) effects the way the body processes oral contraceptive in female participants with obesity or overweight. For each participant, the study will last about 8 months and will include 3 stays in the Clinical Research Unit (CRU), each lasting between 6 - 8 nights.

Trial Details

NCT Number	NCT07808060
Lead Sponsor	Eli Lilly and Company
Conditions	Obesity, Overweight
Enrollment	34 participants
Start Date	2026-09
Primary Completion	2027-06 (estimated)
Study Completion	2027-06 (estimated)
Updated on ClinicalTrials.gov	2026-09-08